 REDWOOD CITY, Calif. BOSTON-- BUSINESS WIRE --Adicet Bio, Inc. Nasdaq: ACET, a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the virtual JMP Securities Hematology and Oncology Summit being held from December 6-7, 2022. 